Patent · US Active

Topical treatment of vitiligo by a jak inhibitor

US11590138B2 · kind B2 · utility

0Cited by

12References

21Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Kathleen BUTLER · Wilmington, US
Jim Lee · Devon, US
Kang Sun · Wallingford, US
Fiona Kuo · West Chester, US
Michael Howell · Kennett Square, US

Key dates

Filing date	Jul 8, 2022
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Jul 8, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.